Synapse - Pergamon-Elsevier Science Ltd

Pergamon-Elsevier Science Ltd

SHERPA: Unknown

People

Heelan
Kris
Miller

Groups

Department of Medicine (1)
Nursing (1)
Solid Tumor Oncology Division (1)
Thoracic Oncology (1)

Search Within

Results (1)

Export to EndNote / Excel

The epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib (TarcevaTM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: Interim results of a phase II trial

Meeting Abstract

Patel, J.; Miller, V.; Kris, M.; Shah, N.; Tyson, L.; Pizzo, B.; Zakowski, M.; Cespon, M.; Heelan, R.; Johnson, D.
EJC Supplements (2003)

Fulltext@MSK | Save

Pergamon-Elsevier Science Ltd – authorized name for:

Pergamon Elsevier Science Ltd
People's Medical Publishing House - USA
Pergamon Elsevier Science Ltd
People's Medical Publishing House
Pergamon Elsevier Science Ltd
Pergamon- Elsevier Science Ltd
Pergamon Elsevier Science, Inc.
Pergamon-Elsevier Science Ltd
Pergamon Elsevier Science Ltd